These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26836152)

  • 1. Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.
    Racine E; Forlini C; Aspler J; Chandler J
    J Alzheimers Dis; 2016; 51(1):1-9. PubMed ID: 26836152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contextualized Autonomy and Liberalism: Broadening the Lenses on Complementary and Alternative Medicines in Preclinical Alzheimer's Disease.
    Racine E; Aspler J; Forlini C; Chandler JA
    Kennedy Inst Ethics J; 2017; 27(1):1-41. PubMed ID: 28366902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.
    Robillard JM
    J Alzheimers Dis; 2016; 51(1):11-3. PubMed ID: 26836156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical dimensions in the borderland between conventional and complementary/alternative medicine.
    Thorne S; Best A; Balon J; Kelner M; Rickhi B
    J Altern Complement Med; 2002 Dec; 8(6):907-15. PubMed ID: 12614541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.
    Prvulovic D; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):517-9. PubMed ID: 22137044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical issues concerning research in complementary and alternative medicine.
    Miller FG; Emanuel EJ; Rosenstein DL; Straus SE
    JAMA; 2004 Feb; 291(5):599-604. PubMed ID: 14762039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Medicine and the Ethics Of Commerce.
    Macdonald C; Gavura S
    Bioethics; 2016 Feb; 30(2):77-84. PubMed ID: 26806450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical implications of the increasing use of complementary and alternative medicine.
    Teichfischer P
    Forsch Komplementmed; 2012; 19(6):311-8. PubMed ID: 23343586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using complementary and alternative approaches for residents with Alzheimer's disease.
    Eliopoulos C
    Director; 2000; 8(1):16. PubMed ID: 11081017
    [No Abstract]   [Full Text] [Related]  

  • 11. [A survey on biomarkers and early diagnosis in Alzheimer's disease].
    Taragano FE; Castro DM; Serrano CM; Heisecke SL; Pérez Leguizamón P; Loñ L; Dillon C
    Medicina (B Aires); 2015; 75(5):282-8. PubMed ID: 26502462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: integrative narrative evolutionary health: toward a wiser view of Alzheimer's disease.
    Whitehouse PJ
    J Altern Complement Med; 2007 Apr; 13(3):341-4. PubMed ID: 17480133
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The concept of complementary and alternative medicine from the perspective of the philosophy of science and bioethics].
    Schöne-Seifert B; Reichardt JO; Friedrich DR; Hucklenbroich P
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(3):236-44. PubMed ID: 26189175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ethical protocol for complementary and alternative medicine practitioners in an orthodox medicine regime.
    Weir M
    J Law Med; 2011 Jun; 18(4):728-36. PubMed ID: 21774270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Defining and disease-modifying therapy for the preclinical stages of Alzheimer's disease].
    Sakurai H; Hanyu H
    Nihon Rinsho; 2016 Mar; 74(3):438-41. PubMed ID: 27025083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From rivalry to rapproachement: biomedicine, Complementary Alternative Medicine (CAM) at ethical crossroads.
    Oguamanam C
    HEC Forum; 2006 Sep; 18(3):245-64. PubMed ID: 17650762
    [No Abstract]   [Full Text] [Related]  

  • 19. Touching ethics: assessing the applicability of ethical rules for safe touch in CAM--outcomes of a CAM (complementary and alternative medicine) practitioner survey in Israel.
    Schiff E; Ben-Arye E; Shilo M; Levy M; Schachter L; Weitchner N; Golan O; Stone J
    Complement Ther Med; 2011 Feb; 19(1):12-8. PubMed ID: 21296262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Legal Implications of Detecting Alzheimer's Disease Earlier.
    Preston J; McTeigue J; Opperman C; Scott Krieg JD; Brandt-Fontaine M; Yasis A; Shen FX
    AMA J Ethics; 2016 Dec; 18(12):1207-1217. PubMed ID: 28009247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.